These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 12375880

  • 1. Cyclohexylamino-demethoxy-hypocrellin B and photodynamic therapy decreases human cancer in vitro.
    Xu S, Chen S, Zhang M, Shen T, Liu Z, Zhao Y, Wu Y.
    Anticancer Drug Des; 2001 Dec; 16(6):271-7. PubMed ID: 12375880
    [Abstract] [Full Text] [Related]

  • 2. Butylamino-demethoxy-hypocrellins and photodynamic therapy decreases human cancer in vitro and in vivo.
    Xu S, Chen S, Zhang M, Shen T, Zhao Y, Liu Z, Wu Y.
    Biochim Biophys Acta; 2001 Nov 29; 1537(3):222-32. PubMed ID: 11731224
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, characterization and photodynamic activity of phenmethylamino-demethoxy-hypocrellin B.
    Xu S, Chen S, Zhang M, Shen T.
    J Photochem Photobiol B; 2003 Dec 05; 72(1-3):61-7. PubMed ID: 14644567
    [Abstract] [Full Text] [Related]

  • 4. EPR studies of the photodynamic properties of a novel potential photodynamic therapeutic agent: photogeneration of semiquinone radical anion and active oxygen species (O2*-, OH*, H2O2 and 1O2).
    Xu S, Zhang X, Chen S, Zhang M, Shen T.
    Photochem Photobiol Sci; 2003 Aug 05; 2(8):871-6. PubMed ID: 14521225
    [Abstract] [Full Text] [Related]

  • 5. Photodynamic properties of dipeptide-modified hypocrellin B derivatives: the role of tyrosine and tryptophan groups.
    Zeng Z, Qiao R, Zhou J, Xia S, Zhang Y, Liu Y, Chen J, Wang X, Zhang B.
    J Phys Chem B; 2007 Apr 12; 111(14):3742-9. PubMed ID: 17388539
    [Abstract] [Full Text] [Related]

  • 6. EPR and spectrophotometric studies on free radicals (O2.-, Cysa-HB.-) and singlet oxygen (1O2) generated by irradiation of cysteamine substituted hypocrellin B.
    He YY, An JY, Jiang LJ.
    Int J Radiat Biol; 1998 Nov 12; 74(5):647-54. PubMed ID: 9848284
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
    Chin W, Lau W, Cheng C, Olivo M.
    Int J Oncol; 2004 Sep 12; 25(3):623-9. PubMed ID: 15289863
    [Abstract] [Full Text] [Related]

  • 8. Photodynamic action of amino substituted hypocrellins: EPR studies on the photogenerations of active oxygen and free radical species.
    Wu T, Shen J, Song A, Chen S, Zhang M, Shen T.
    J Photochem Photobiol B; 2000 Aug 12; 57(1):14-21. PubMed ID: 11100833
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and characterization of three novel amphiphilic aminated hypocrellins as photodynamic therapeutic agents.
    Xu S, Chen S, Zhang M, Shen T, Zhang X, Wang Z.
    Photochem Photobiol; 2003 Oct 12; 78(4):411-5. PubMed ID: 14626671
    [Abstract] [Full Text] [Related]

  • 10. Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo.
    Liu CD, Kwan D, Saxton RE, McFadden DW.
    J Surg Res; 2000 Sep 12; 93(1):137-43. PubMed ID: 10945955
    [Abstract] [Full Text] [Related]

  • 11. Mitochondrial reactive oxygen species and nitric oxide-mediated cancer cell apoptosis in 2-butylamino-2-demethoxyhypocrellin B photodynamic treatment.
    Lu Z, Tao Y, Zhou Z, Zhang J, Li C, Ou L, Zhao B.
    Free Radic Biol Med; 2006 Nov 15; 41(10):1590-605. PubMed ID: 17045927
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo antitumor activity of a novel hypocrellin B derivative for photodynamic therapy.
    Zhao H, Yin R, Chen D, Ren J, Wang Y, Zhanga J, Deng H, Wang Y, Qiu H, Huang N, Zou Q, Zhao J, Gu Y.
    Photodiagnosis Photodyn Ther; 2014 Jun 15; 11(2):204-12. PubMed ID: 24534694
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and EPR investigations of new aminated hypocrellin derivatives.
    He YY, Jiang LJ.
    Free Radic Biol Med; 2000 Jun 01; 28(11):1642-51. PubMed ID: 10938461
    [Abstract] [Full Text] [Related]

  • 14. Effect of structural modifications on photosensitizing activities of hypocrellin dyes: EPR and spectrophotometric studies.
    Yuying H, Jingyi A, Lijin J.
    Free Radic Biol Med; 1999 May 01; 26(9-10):1146-57. PubMed ID: 10381185
    [Abstract] [Full Text] [Related]

  • 15. Photodynamic properties of a bispyrrolecarboxamide-modified hypocrellin B: the role of affinity and ascorbic acid.
    Liu Y, Zhou Q, Zeng Z, Qiao R, Wang X, Zhang B.
    J Phys Chem B; 2008 Aug 14; 112(32):9959-65. PubMed ID: 18646820
    [Abstract] [Full Text] [Related]

  • 16. Photosensitization mechanism of active species by the complex of hypocrellin B with aluminum ion.
    Ma JH, Zhao JQ, Jiang LJ.
    Free Radic Res; 2001 Nov 14; 35(5):607-17. PubMed ID: 11767418
    [Abstract] [Full Text] [Related]

  • 17. New potential photodynamic therapeutic anti-cancer agents: synthesis and characterization of demethoxy amino-substituted hypocrellins.
    Wu T, Xu S, Shen J, Song A, Chen S, Zhang M, Shen T.
    Anticancer Drug Des; 2000 Aug 14; 15(4):287-93. PubMed ID: 11200504
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, characterization and photodynamic activity of amino-substituted hypocrellin derivatives.
    Tang YJ, Liu HY, An JY, Han R.
    Photochem Photobiol; 2001 Aug 14; 74(2):201-5. PubMed ID: 11547555
    [Abstract] [Full Text] [Related]

  • 19. Studies on the synthesis of two hydrophilic hypocrellin derivatives with enhanced absorption in the red spectral region and on their photogeneration of O2*- and O2(1(delta)g).
    Lee HY, Chen S, Zhang MH, Shen T.
    J Photochem Photobiol B; 2003 Oct 15; 71(1-3):43-50. PubMed ID: 14705638
    [Abstract] [Full Text] [Related]

  • 20. Exploitation of immune response-eliciting properties of hypocrellin photosensitizer SL052-based photodynamic therapy for eradication of malignant tumors.
    Korbelik M, Merchant S, Huang N.
    Photochem Photobiol; 2009 Oct 15; 85(6):1418-24. PubMed ID: 19709384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.